# Synkrino Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synkrino-biotherapeutics

- Industry: Biotechnology
- Headquarters: Berkeley, US
- Website: www.synkrino.bio
- Total disclosed funding: $1M
- Latest round: Seed (Jul 1, 2018)
- Investors on record: 1

## About

Founded in 2018 and based in California, US, Synkrino Biotherapeutics, Inc. offers an AI-powered biotech platform that discovers and develops drug targets from the immune system of patients.

## Funding rounds

- Seed, Jul 1, 2018, $1M — Blue Bear Ventures

## Investors

- Blue Bear Ventures (https://capitalatlas.ai/funds/blue-bear-ventures) — Seed